Molecular Endocrinology · 2010 · 236 citations · 36 references
Life SciencesEndocrinologyMolecular BiologyCell SignalingSignal TransductionTranscriptional RegulationG Protein-coupled Receptor SignalingHormone Gene RegulationHormone ReceptorsHormone SignalingNuclear ReceptorsSteroid Hormone SignalingActivator Protein 1 ActivationActivator ProteinsEstrogen Receptor ExpressionEstrogen Receptor SignalingEstrogen ReceptorsNongenomic SignalingOrphan G Protein-coupled ReceptorsPromoter Activity Analysis
Accumulating evidence suggested that an orphan G protein-coupled receptor (GPR)30, mediates nongenomic responses to estrogen. The present study was performed to investigate the molecular mechanisms underlying GPR30 function. We found that knockdown of GPR30 expression in breast cancer SK-BR-3 cells down-regulated the expression levels of estrogen receptor (ER)-alpha36, a variant of ER-alpha. Introduction of a GPR30 expression vector into GPR30 nonexpressing cells induced endogenous ER-alpha36 expression, and cotransfection assay demonstrated that GPR30 activated the promoter activity of ER-alpha36 via an activator protein 1 binding site. Both 17beta-estradiol (E2) and G1, a compound reported to be a selective GPR30 agonist, increased the phosphorylation levels of the MAPK/ERK1/2 in SK-BR-3 cells, which could be blocked by an anti-ER-alpha36-specific antibody against its ligand-binding domain. G1 induced activities mediated by ER-alpha36, such as transcription activation activity of a VP16-ER-alpha36 fusion protein and activation of the MAPK/ERK1/2 in ER-alpha36-expressing cells. ER-alpha36-expressing cells, but not the nonexpressing cells, displayed high-affinity, specific E2 and G1 binding, and E2- and G1-induced intracellular Ca(2+) mobilization only in ER-alpha36 expressing cells. Taken together, our results demonstrated that previously reported activities of GPR30 in response to estrogen were through its ability to induce ER-alpha36 expression. The selective G protein-coupled receptor (GPR)30 agonist G1 actually interacts with ER-alpha36. Thus, the ER-alpha variant ER-alpha36, not GPR30, is involved in nongenomic estrogen signaling.
36
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
Chetana M. Revankar, Daniel F. Cimino, Larry A. Sklar et al. · Science · 2005 · 2.3K citations
Dennis B. Lubahn, Jeffrey S. Moyer, T S Golding et al. · Proceedings of the National Academy of Sciences · 1993 · 1.8K citations · Full text
Medicine, Endocrinology, Genetics +17
Edward J. Filardo, Jeffrey A. Quinn, Kirby I. Bland et al. · Molecular Endocrinology · 2000 · 1.3K citations · Full text
Mahnaz Razandi, Ali Pedram, Geoffrey L. Greene et al. · Molecular Endocrinology · 1999 · 1K citations · Full text